EN
HI
Ipca Laboratories Chart
Ipca Laboratories Share Key Metrics
Volume
2.73 L
Market Cap
41774.94 CR
LTQ@LTP
15@1646.60
ATP
1654.49
Var Margin
15.7 %
Circuit Range
1325-1987.4
Delivery %
50.24 %
Value
45.18 CR
ASM/GSM
No
Market Lot
1
Summary
Ipca Laboratories share price is ₹1646.6 as of 21 May, 2026. The stock Ipca Laboratories intraday movement has stayed between ₹1635.30 and ₹1678.30, while on a 52-week basis,Ipca Laboratories price 52 week high is ₹1678.30 & its 52 week low is ₹1251.60.
In terms of trading activity, Ipca Laboratories has recorded a volume of 273088 shares, The Ipca Laboratories has a market cap of ₹253704218 CR. The stock’s Average Traded Price (ATP) stands at ₹1654.49, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 15 @ ₹1646.60.
Ipca Laboratories operates within a circuit range of ₹1325.00 – ₹1987.40, with a Value of ₹45.18 CR. The Delivery Percentage for the day is 50.24%. Additionally, Ipca Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Ipca Laboratories Fundamentals
View MoreP/E Ratio
46.13
P/B Ratio
5.39
Div. Yield
0.24
Sector P/E
71.7
Sector P/B
3.51
Sec. Div. Yield
0.56
Ipca Laboratories Resistance and Support
Pivot 1650.8
Resistance
First Resistance
1667.6
Second Resistance
1679
Third Resistance
1695.8
Support
First Support
1639.4
Second Support
1622.6
Third Support
1611.2
Ipca Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results & Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
Ipca Laboratories News
Ipca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend
IPCA Laboratories board will hold a meeting on May 29, 2026, to review and approve the audited financial results for the fourth quarter and full financial year ended March 31, 2026. The board will also consider the recommendation of a dividend for the financial year 2025-26.
May 04 2026 16:05:00
About Ipca Laboratories
NSE : 1633
BSE : 524494
ISIN : INE571A01038
Ipca Laboratories Management
| Name | Position |
|---|---|
| Harish P Kamath | Corporate Counsel & Company Secretary, Compliance Officer |
| Premchand Godha | Chairman |
Ipca Laboratories Similar Stocks
Biocon Ltd.
432.70
4.55 (1.06%)
Glenmark Pharmaceuticals Ltd.
2379.00
-26.90 (1.12%)
Alkem Laboratories Ltd.
5436.50
-33.50 (0.61%)
Abbott India Ltd.
27445.00
-350.00 (1.26%)
Anthem Biosciences Ltd.
780.50
-6.85 (0.87%)
Glaxosmithkline Pharmaceuticals Ltd.
2346.80
-42.60 (1.78%)
Ajanta Pharma Ltd.
3188.80
-59.40 (1.83%)
Aster DM Healthcare Ltd.
764.85
15.95 (2.13%)
Narayana Hrudayalaya Ltd.
1902.40
18.30 (0.97%)
Gland Pharma Ltd.
2221.80
-29.30 (1.30%)
Ipca Laboratories FAQs
The Buying Price of Ipca Laboratories share is 1646.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ipca Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ipca Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ipca Laboratories shares is 46.13. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ipca Laboratories shares is 5.39. Useful to assess the stock's value relative to its book value.
To assess Ipca Laboratories’s valuation compare Sector P/E, P/B which are 71.7 & 3.51 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ipca Laboratories is 41774.94 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ipca Laboratories share price is 1678.30 & 1251.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ipca Laboratories belongs to the Healthcare sector.
